WALTER MARBACH, MD
Rheumatology Physician · CRESTWOOD, IL
Individual Active NPI 1891703591
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 553 | 354,350 | $9,092,713 | $3,501,561 | $2,786,922 |
| 2023 | 486 | 263,086 | $8,685,098 | $3,474,466 | $2,759,281 |
| 2022 | 464 | 262,177.9 | $10,021,984 | $4,098,349 | $3,262,029 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0878 | Injection, daptomycin, 1 mg | 188,320 | $0 | $0 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 21,300 | $22 | $17 |
| J0485 | Injection, belatacept, 1 mg | 21,002 | $4 | $3 |
| J0875 | Injection, dalbavancin, 5 mg | 12,600 | $15 | $12 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 11,340 | $18 | $14 |
| J2357 | Injection, omalizumab, 5 mg | 7,545 | $38 | $30 |
| J1306 | Injection, inclisiran, 1 mg | 5,680 | $12 | $9 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,430 | $31 | $25 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 4,672 | $45 | $36 |
| J2182 | Injection, mepolizumab, 1 mg | 4,100 | $30 | $24 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,835 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 1,800 | $26 | $20 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Rheumatology Physician | 207RR0500X | ✓ | 036-057150 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Rheumatology Physician providers in Illinois
- NPI 1801950852
- NPI 1790102804
- NPI 1932546249
- NPI 1083124465
- NPI 1144473745
- NPI 1619921541
- NPI 1386075893
- NPI 1831316983
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.